$CNTX 4 SEC Filings

Filed On	Filing
26 Jun 2026	Form 4: Pasternak Andy, Director Granted 45,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Smith Karen L., Director Granted 45,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Stacey Jennifer Evans, Director Granted 45,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Walker Luke Nathaniel, Director Granted 45,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Kantoff Philip W., Director Granted 45,000 Stock Option (right to buy)
26 Jun 2026	Form 4: West Linda, Director Granted 45,000 Stock Option (right to buy)
23 Feb 2026	Form 4: Levit Alex C., Chief Legal Officer, Corp. Sec Granted 270,000 Stock Option (right to buy)
23 Feb 2026	Form 4: Minai-Azary Jennifer Lynn, Chief Financial Officer Granted 275,000 Stock Option (right to buy)
23 Feb 2026	Form 4: Chagin Karen Deborah, Chief Medical Officer Granted 290,000 Stock Option (right to buy)
23 Feb 2026	Form 4: Lehr Martin A., Director Granted 815,000 Stock Option (right to buy)
12 Jun 2025	Form 4: Smith Karen L., Director Granted 123,500 Stock Option (right to buy)
12 Jun 2025	Form 4: Pasternak Andy, Director Granted 138,900 Stock Option (right to buy)
12 Jun 2025	Form 4: Kantoff Philip W., Director Granted 123,500 Stock Option (right to buy)
12 Jun 2025	Form 4: Stacey Jennifer Evans, Director Granted 123,500 Stock Option (right to buy)
12 Jun 2025	Form 4: Walker Luke Nathaniel, Director Granted 123,500 Stock Option (right to buy)
12 Jun 2025	Form 4: West Linda, Director Granted 123,500 Stock Option (right to buy)
10 Jun 2025	Form 4: Lehr Martin A., Director Bought 100,000 shares ($70.1K)
10 Jun 2025	Form 4: Levit Alex C., Chief Legal Officer, Corp. Sec Bought 20,000 shares ($11.5K)
10 Jun 2025	Form 4: Minai-Azary Jennifer Lynn, Chief Financial Officer Bought 40,010 shares ($25.5K)
09 Jun 2025	Form 4: Chagin Karen Deborah, Chief Medical Officer Granted 153,000 Stock Option (right to buy)

Comments